This 88-hour on-demand conference includes 64 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 6-hour, on-demand course will equip healthcare providers with the necessary tools to make a meaningful difference in the lives of women facing addiction.

This 75-minute on-demand session from the ASAM 57th Annual Conference addresses addiction medication use in adolescents with SUD, including risk-benefit considerations, family involvement, and expanding treatment access.

This one-hour, journal article-based activity examines the relationships between childhood trauma, chronic pain, and substance use among individuals receiving methadone treatment for opioid use disorder (OUD). Using validated measures of trauma exposure, pain severity, and recent substance use, the study identifies clinically relevant associations between early life adversity and adult pain and substance use patterns. Findings highlight the importance of integrating trauma-informed assessment and care into OUD treatment settings, particularly for patients experiencing co-occurring pain and substance use behaviors.

This 35-minute, on-demand session from the ASAM 2025 Review Course covers the principles, supportive research, applications, and challenges for a variety of common psychosocial interventions including 12-step support models.

This 30-minute, on-demand session from the ASAM 2025 Review Course covers evidence-based modalities such as Cognitive Behavioral Therapy (CBT), Motivational Interviewing (MI), Dialectical Behavioral Therapy, Network Therapies, and case management as they relate to addiction treatment.

This 45-minute, on-demand session from the ASAM 2025 Review Course focuses on the interactions between disorders, differential diagnoses, and management as well as a framework to assess patients for psychiatric co-morbidities.

This 2-hour, on-demand session from the 2024 ASAM State of the Art Course focuses on the prevention and treatment of stimulant use disorders and will discuss topics such as new clinical practice guidelines, novel pharmacotherapies, methamphetamine-induced psychotic disorders, and more.

This 1-hour, on-demand session from the 2024 ASAM State of the Art Course covers most recent updates on emerging issues and advances in addiction medicine from the perspective of three major federal agencies: NIAAA, SAMHSA, and NIDA.

This 1-hour and 45-minute, on-demand session from the 2024 ASAM State of the Art Course discusses tobacco use in different populations, GLP-1 use for smoking cessation, comparative effectiveness of treatment models, and more, to provide a comprehensive overview of the state of the art of treatment for nicotine use disorder.